V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260006123 | 260011156 | 1.62 | 58.4 | Palliative (P) | 2013-08-25 | 2013-09-01 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023231 | BENDAMUSTINE + RITUXIMAB |
| 260006124 | 260011156 | 1.7 | 98.6 | Palliative (P) | 2018-10-16 | 2018-10-16 | BENDAMUSTINE + RITUXIMAB | N | N | 260023231 | BENDAMUSTINE + RITUXIMAB |
| 260006125 | 260004579 | 1.71 | 82.1 | Disease modification (D) | 2014-04-04 | 2014-04-04 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023233 | BENDAMUSTINE + RITUXIMAB |
| 260006126 | 260004580 | 1.73 | 88.8 | Curative (C) | null | 2017-07-01 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023234 | BENDAMUSTINE + RITUXIMAB |
| 260006127 | 260004581 | 1.79 | 99.8 | Curative (C) | 2015-01-28 | 2015-01-28 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023235 | BENDAMUSTINE + RITUXIMAB |
| 260006128 | 260011157 | 1.8 | 79.5 | Palliative (P) | 2016-01-16 | 2016-01-21 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023237 | BENDAMUSTINE + RITUXIMAB |
| 260006129 | 260004582 | 1.83 | 102 | Disease modification (D) | 2016-12-05 | 2016-12-10 | Bendamustine+Rituximab (1st Course) | N | null | 260023242 | BENDAMUSTINE + RITUXIMAB |
| 260006130 | 260004582 | 1.62 | 73.8 | Curative (C) | 2013-07-20 | 2013-07-24 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023242 | BENDAMUSTINE + RITUXIMAB |
| 260006131 | 260004583 | 1.64 | 50.2 | Disease modification (D) | 2014-12-12 | 2014-12-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023244 | BENDAMUSTINE + RITUXIMAB |
| 260006132 | 260004583 | 1.56 | 89 | Disease modification (D) | 2016-06-29 | 2016-07-10 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023244 | BENDAMUSTINE + RITUXIMAB |
| 260006133 | 260004583 | 1.61 | null | Disease modification (D) | 2014-03-26 | 2014-03-30 | BENDAMUSTINE + RITUXIMAB | N | null | 260023244 | BENDAMUSTINE + RITUXIMAB |
| 260006134 | 260004583 | 1.6 | null | null | 2017-04-30 | 2017-05-11 | BENDAMUSTINE + RITUXIMAB | Y | N | 260023244 | BENDAMUSTINE + RITUXIMAB |
| 260006135 | 260004584 | 1.75 | 108 | Palliative (P) | 2017-09-04 | 2017-09-12 | Bendamustine+Rituximab (1st Course) | N | N | 260023255 | BENDAMUSTINE + RITUXIMAB |
| 260006136 | 260004584 | 1.83 | 90.3 | Disease modification (D) | 2015-10-10 | 2015-10-16 | BENDAMUSTINE + RITUXIMAB | N | N | 260023255 | BENDAMUSTINE + RITUXIMAB |
| 260006137 | 260004585 | 1.76 | 70.2 | Palliative (P) | 2015-01-25 | 2015-02-01 | Bendamustine+Rituximab(Sub Courses) | N | N | 260023262 | BENDAMUSTINE + RITUXIMAB |
| 260006138 | 260011161 | null | 96.4 | null | null | 2015-01-31 | BENDAMUSTINE + RITUXIMAB | null | null | 260023263 | BENDAMUSTINE + RITUXIMAB |
| 260006139 | 260011161 | 1.9 | 77.2 | Palliative (P) | 2017-11-29 | 2017-12-12 | Bendamustine+Rituximab (1st Course) | N | N | 260023263 | BENDAMUSTINE + RITUXIMAB |
| 260006140 | 260004586 | 1.85 | 84 | Disease modification (D) | null | 2016-09-19 | BENDAMUSTINE + RITUXIMAB | N | N | 260023266 | BENDAMUSTINE + RITUXIMAB |
| 260006141 | 260011162 | 1.63 | 100 | Disease modification (D) | null | 2015-08-26 | BENDAMUSTINE + RITUXIMAB | N | N | 260023267 | BENDAMUSTINE + RITUXIMAB |
| 260006143 | 260004588 | 1.75 | 111 | Disease modification (D) | 2016-08-23 | 2016-08-23 | Bendamustine+Rituximab (1st Course) | 2 | N | 260023270 | BENDAMUSTINE + RITUXIMAB |
| 260006144 | 260004588 | 1.74 | 83 | Palliative (P) | 2017-12-07 | 2017-12-07 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023270 | BENDAMUSTINE + RITUXIMAB |
| 260006145 | 260004589 | 1.79 | 85.5 | Palliative (P) | 2018-03-04 | 2018-03-08 | BENDAMUSTINE + RITUXIMAB | N | N | 260023274 | BENDAMUSTINE + RITUXIMAB |
| 260006146 | 260004590 | 1.71 | 79 | Palliative (P) | 2017-08-24 | 2017-08-24 | BENDAMUSTINE + RITUXIMAB | N | N | 260023277 | BENDAMUSTINE + RITUXIMAB |
| 260006147 | 260004590 | 1.77 | 99.3 | Palliative (P) | 2017-06-21 | 2017-06-27 | Bendamustine+Rituximab (1st Course) | N | N | 260023277 | BENDAMUSTINE + RITUXIMAB |
| 260006148 | 260004591 | 1.79 | 94 | Palliative (P) | 2014-10-06 | 2014-10-09 | BENDAMUSTINE + RITUXIMAB | N | N | 260023281 | BENDAMUSTINE + RITUXIMAB |
| 260006149 | 260004591 | 1.58 | 48.25 | null | 2014-03-14 | 2014-03-17 | BENDAMUSTINE + RITUXIMAB | N | null | 260023281 | BENDAMUSTINE + RITUXIMAB |
| 260006151 | 260004593 | 1.7 | 69.1 | Palliative (P) | 2016-02-10 | 2016-02-14 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023288 | BENDAMUSTINE + RITUXIMAB |
| 260006152 | 260004594 | 1.55 | 75.8 | Palliative (P) | 2016-12-03 | 2016-12-03 | Bendamustine+Rituximab (1st Course) | N | N | 260023289 | BENDAMUSTINE + RITUXIMAB |
| 260006153 | 260004594 | 1.86 | 69 | Disease modification (D) | 2014-10-26 | 2014-10-26 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023289 | BENDAMUSTINE + RITUXIMAB |
| 260006154 | 260004595 | 1.74 | null | null | 2013-12-02 | 2013-12-10 | BENDAMUSTINE + RITUXIMAB | N | null | 260023291 | BENDAMUSTINE + RITUXIMAB |
| 260006155 | 260004595 | 1.59 | 71 | Palliative (P) | 2013-03-16 | 2013-03-21 | BENDAMUSTINE + RITUXIMAB | N | N | 260023291 | BENDAMUSTINE + RITUXIMAB |
| 260006156 | 260004596 | 1.67 | 51 | Palliative (P) | 2016-02-14 | 2016-02-17 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023293 | BENDAMUSTINE + RITUXIMAB |
| 260006157 | 260004596 | 1.71 | 88.5 | Palliative (P) | null | 2015-03-30 | Bendamustine+Rituximab(Sub Courses) | null | null | 260023293 | BENDAMUSTINE + RITUXIMAB |
| 260006158 | 260004596 | 1.8 | 78 | Disease modification (D) | 2015-10-16 | 2015-10-30 | BENDAMUSTINE + RITUXIMAB | N | N | 260023293 | BENDAMUSTINE + RITUXIMAB |
| 260006159 | 260004597 | 1.52 | 58.1 | Palliative (P) | 2016-07-13 | 2016-07-14 | Bendamustine+Rituximab (1st Course) | N | N | 260023296 | BENDAMUSTINE + RITUXIMAB |
| 260006160 | 260004597 | 1.61 | 59.6 | Curative (C) | null | 2014-12-22 | Bendamustine+Rituximab (1st Course) | N | N | 260023296 | BENDAMUSTINE + RITUXIMAB |
| 260006161 | 260004597 | 1.65 | 58.4 | Palliative (P) | 2016-06-18 | 2016-06-19 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023296 | BENDAMUSTINE + RITUXIMAB |
| 260006162 | 260004598 | 1.8 | 73.4 | Palliative (P) | 2018-10-20 | 2018-10-25 | BENDAMUSTINE + RITUXIMAB | 2 | N | 260023300 | BENDAMUSTINE + RITUXIMAB |
| 260006163 | 260004599 | null | null | Disease modification (D) | 2017-08-12 | 2017-08-12 | BENDAMUSTINE + RITUXIMAB | 02 | null | 260023301 | BENDAMUSTINE + RITUXIMAB |
| 260006164 | 260011170 | 1.75 | 124 | Disease modification (D) | 2014-12-15 | 2014-12-15 | BENDAMUSTINE + RITUXIMAB | N | N | 260023302 | BENDAMUSTINE + RITUXIMAB |
| 260006165 | 260004600 | 1.56 | 46.4 | Palliative (P) | null | 2013-11-13 | Bendamustine+Rituximab(Sub Courses) | N | Y | 260023306 | BENDAMUSTINE + RITUXIMAB |
| 260006166 | 260004601 | 1.81 | 96 | Disease modification (D) | 2014-02-10 | 2014-02-12 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 260023308 | BENDAMUSTINE + RITUXIMAB |
| 260006167 | 260004601 | 1.8 | 79 | null | 2014-02-03 | 2014-02-04 | Bendamustine+Rituximab (1st Course) | 02 | N | 260023308 | BENDAMUSTINE + RITUXIMAB |
| 260006168 | 260004602 | 1.78 | 93 | Curative (C) | null | 2017-12-02 | BENDAMUSTINE + RITUXIMAB | N | N | 260023310 | BENDAMUSTINE + RITUXIMAB |
| 260006169 | 260004602 | 1.75 | 90 | Palliative (P) | 2016-04-17 | 2016-04-17 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023310 | BENDAMUSTINE + RITUXIMAB |
| 260006170 | 260004603 | 1.65 | 90 | null | 2015-11-12 | 2015-11-17 | BENDAMUSTINE + RITUXIMAB | N | null | 260023312 | BENDAMUSTINE + RITUXIMAB |
| 260006171 | 260004604 | 1.84 | 90.4 | Disease modification (D) | 2015-12-16 | 2015-12-16 | BENDAMUSTINE + RITUXIMAB | 02 | N | 260023314 | BENDAMUSTINE + RITUXIMAB |
| 260006173 | 260004605 | 1.75 | 87 | Disease modification (D) | 2018-03-01 | 2018-03-22 | BENDAMUSTINE + RITUXIMAB | N | N | 260023317 | BENDAMUSTINE + RITUXIMAB |
| 260006174 | 260004605 | 1.69 | 87 | Palliative (P) | 2015-01-27 | 2015-01-27 | BENDAMUSTINE + RITUXIMAB | N | N | 260023317 | BENDAMUSTINE + RITUXIMAB |
| 260006175 | 260004605 | 1.73 | 142.5 | Disease modification (D) | null | 2014-02-15 | Bendamustine+Rituximab (1st Course) | N | N | 260023317 | BENDAMUSTINE + RITUXIMAB |